Citations

Clear

4847 citation(s) found for "Yu, Eric".

Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
Sandoval, Yader , Lewis, Bradley R., Mehta, Ramila A. , Ola, Olatunde , Knott, Jonathan D , Michieli, Laura De , Akula, Ashok , Lobo, Ronstan , Gharacholou, S. Michael , Dworak, Marshall , Crockford, Erika, Rastas, Nicholas, Grube, Eric , Karturi, Swetha, Wohlrab, Scott, Hodge, David O. , Tak, Tahir , Cagin, Charles , Gulati, Rajiv , Jaffe, Allan S. , Lewis, Bradley R , De Michieli, Laura , Dworak, Marshall , Gulati, Rajiv , Jaffe, Allan S. , Yang, Eric H. , Grube, Eric

Mayo Clinic

Circulation | May 10, 2022 | Volume: 145 | Issue: 23 | Pages: 1708-1719

10.1161/circulationaha.122.059235 | PMID 35535607 Get It

Background: There are good data to support using a single high-sensitivity cardiac troponin T (hs-cTnT) below the limit of detection of 5 ng/L to exclude acute myocardial infarction. Per the US Food and Drug Administration, hs-cTnT can only report to the limit of quantitation of 6 ng/L, a threshold for which there are limited data. Our goal was to determine whether a single hs-cTnT below the limit of quantitation of 6 ng/L is a safe strategy to identify patients at low risk for acute myocardial injury and infarction. Methods: The efficacy (proportion identified as low risk based on baseline hs-cTnT<6 ng/L) of identifying low-risk patients was examined in a multicenter (n=22 sites) US cohort study of emergency department patients undergoing at least 1 hs-cTnT (CV Data Mart Biomarker cohort). We then determined the performance of a single hs-cTnT<6 ng/L (biomarker alone) to exclude acute myocardial injury (subsequent hs-cTnT >99th percentile in those with an initial hs-cTnT<6 ng/L). The clinically intended rule-out strategy combining a nonischemic ECG with a baseline hs-cTnT<6 ng/L was subsequently tested in an adjudicated cohort in which the diagnostic performance for ruling out acute myocardial infarction and safety (myocardial infarction or death at 30 days) were evaluated. Results: A total of 85 610 patients were evaluated in the CV Data Mart Biomarker cohort, among which 24 646 (29%) had a baseline hs-cTnT<6 ng/L. Women were more likely than men to have hs-cTnT<6 ng/L (38% versus 20%, P <0.0001). Among 11 962 patients with baseline hs-cTnT<6 ng/L and serial measurements, only 1.2% developed acute myocardial injury, resulting in a negative predictive value of 98.8% (95% CI, 98.6–99.0) and sensitivity of 99.6% (95% CI, 99.5–99.6). In the adjudicated cohort, a nonischemic ECG with hs-cTnT<6 ng/L identified 33% of patients (610/1849) as low risk and resulted in a negative predictive value and sensitivity of 100% and a 30-day rate of 0.2% for myocardial infarction or death. Conclusions: A single hs-cTnT below the limit of quantitation of 6 ng/L is a safe and rapid method to identify a substantial number of patients at very low risk for acute myocardial injury and infarction.
Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis‐associated interstitial lung disease and idiopathic pulmonary fibrosis
Wang, Shaohua , Liu, Mengfei , Zhang, Jie , Wang, Faping , Zhang, Chujie , Roden, Anja C. , Ryu, Jay H. , Matteson, Eric L. , Tschumperlin, Daniel J. , Vassallo, Robert , Roden, Anja, Vassallo, Robert , Ryu, Jay H , Li, Xiujuan , Warrington, Kenneth J. , Sun, Jie

Mayo Clinic

The FASEB Journal | May 6, 2022 | Volume: 36 | Issue: 6 | Pages: No page available

10.1096/fj.202101436r | PMID 35522243 Get It

Abstract Idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) are two fibrotic interstitial lung diseases that share the usual interstitial pneumonia (UIP) injury pattern. Here, we report that RNA sequencing of lung biopsies from patients with RA‐ILD and IPF revealed shared and distinct disease‐causing pathways. Analysis of transcriptomic data identified a JAK2 related JAK/STAT signaling pathway gene signature that distinguishes RA‐UIP from idiopathic UIP. This was further confirmed by immunohistostaining, which identified JAK2 phosphorylation with two distinct forms of activation: a cytoplasmic form of JAK2 activation in most IPF cases (13/20) and a nuclear form of p‐JAK2 in RA‐UIP (5/5) and a minority of IPF (6/20) cases. Further immunohistostaining identified STAT5A&B as the downstream transcriptional activator for JAK2‐mediated canonical signal transduction and phosphorylation of Tyr41 on histone H3 (H3Y41ph) as the downstream epigenetic regulation site for JAK2‐mediated noncanonical signal transduction. Gene Set Enrichment Analysis (GSEA) of the RNA‐Seq data further supported this shared pathogenic mechanism for the two diseases with the enrichment of STAT5A&B target gene sets as well as the JAK2 regulated H3Y41ph target gene set. This regulatory role of JAK2 in the pathogenesis of pulmonary fibrosis was further demonstrated by the attenuation of bleomycin‐induced murine pulmonary fibrosis using a JAK2‐selective pharmacological inhibitor CEP33779. In vitro studies with normal and IPF derived lung fibroblasts revealed a central role for JAK2 as an essential intermediary molecule in TGF‐β‐mediated myofibroblast trans‐differentiation, proliferation, and extracellular matrix protein production. These observations support a crucial role for JAK2 as an intermediary molecule in fibrotic lung disease development.
FC044: Heterozygous Variants in Kinase Domain of NEK8 cause an Autosomal-Dominant Ciliopathy
Claus, Laura R. , Stallworth, Jennifer L., Turner, Joshu, Hawks, Alexandra L. , May, Melanie , Louie, Raymond J. , Silver, Josh, Lerner-Ellise, Jordan, Morel, Chantal F. , Mighton, Chloe, Ziegler, Alban , Larsen, Martin J. , Lilien, Marc, Obeidová, Lena , Senum, Sarah R. , Rogers, Curtis , Duran, Karen, Peters, Edith, Senum, Sarah R , Jaarsveld, Richard H. van , Turner, Joshua L. , Flanagan‐Steet, Heather R. , Barakat, Tahsin Stefan , Dahan, Karin , Demoulin, Nathalie , Goffin, Eric Jean , Hertz, Jens Michael , Olinger, Eric , Sayer, John A , Seeman, Tomáš , Hanna, Christian , Harris, Peter C. , Mason, Jennifer M. , Haaften, Gijs W van , Eerde, Albertien M. van , Steet, Richard

Mayo Clinic

Nephrology Dialysis Transplantation | May 5, 2022 | Volume: 37 | Issue: Supplement_3 | Pages: No page available

10.1093/ndt/gfac104.004 Get It

Abstract BACKGROUND AND AIMS NEK8/NPHP9 encodes a protein that localizes to the primary cilium. Biallelic NEK8 variants are known to cause multiorgan developmental defects, including kidney cystic dysplasia and extensive extra-renal defects, with heterozygous carrier parents being asymptomatic [1]. This autosomal recessive inheritance is the most common inheritance mode for ciliopathies. Complementary to this, we now propose a dominant negative effect for specific heterozygous NEK8 missense variants in the kinase domain resulting in an autosomal-dominant ciliopathy. METHOD We performed genetic testing in patients from several medical centers. To explore the consequences of the identified NEK8 variants, we are performing cilia staining assays in patients' skin fibroblast and kidney cells, as well as in mIMCD3 cells overexpressing the identified variants. Furthermore, we are examining the impact of the NEK8 variants on replication stress response. RESULTS We identified three distinct heterozygous NEK8 variants in 12 families (Table 1), all leading to missense alterations in the kinase domain. Interestingly the p.Arg45Trp variant is a recurrent variant we detected in 10 unrelated families. All patients have a kidney phenotype that varies from mild focal segmental glomerulosclerosis to prenatal presentation with polycystic kidneys. Most patients have kidney failure needing kidney replacement therapy at varying ages of onset. In all patients, we thoroughly checked whether a second variant could be found. Furthermore, the large symptomatic family and de novo occurrences favor a dominant inheritance mode. Our preliminary results from functional studies show abnormal primary cilia formation in serum-starved cells as well as increased replication stress. CONCLUSION We present the first evidence for a pathogenic effect of heterozygous NEK8 variants. Remarkably our patients present with a kidney limited phenotype as compared to the multiorgan defects found in patients with biallelic variants. This reveals a new mode of inheritance for NEK8 variants and expands genotype-phenotype correlations for this gene.
Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MIND
Goldstein, Eric , Wolcott, Zoe , Garg, Gauri, Navarro, Kayla , Delic, Alen, Yaghi, Shadi , Sederholm, Benson , Prabhakaran, Shyam , Wong, Ka-Ho , McLean, Kaitlin, Goldstein, Eric D , de Havenon, Adam H , Yaghi, Shadi , Prabhakaran, Shyam , Wolcott, Zoe , Garg, Gauri, Navarro, Kayla , Delic, Alen, Sederholm, Benson , Wong, Ka-Ho , McLean, Kaitlin

Mayo Clinic

Stroke | May 4, 2022 | Volume: 53 | Issue: 8 | Pages: 2435-2440

10.1161/strokeaha.121.037997 | PMID 35506388 Get It

Background: Treatment of uncontrolled arterial hypertension reduces the risk of cerebral small vessel disease (CSVD) progression, although it is unclear whether this reduction occurs due to blood pressure control or class-specific pleiotropic effects, such as improved beat-to-beat arterial pressure variability with calcium channel blockers. The goal of this study was to investigate the influence of antihypertensive medication class, particularly with calcium channel blocker, on accumulation of white matter hyperintensities (WMH), a radiographic marker of CSVD, within a cohort with well-controlled hypertension. Methods: We completed an observational cohort analysis of the SPRINT-MIND trial (Systolic Blood Pressure Trial Memory and Cognition in Decreased Hypertension), a large randomized controlled trial of participants who completed a baseline and 4-year follow-up brain magnetic resonance image with volumetric WMH data. Antihypertensive medication data were recorded at follow-up visits between the magnetic resonance images. A percentage of follow-up time participants were prescribed each of the 11 classes of antihypertensive was then derived. Progression of CSVD was calculated as the difference in WMH volume between 2 scans and, to address skew, dichotomized into a top tertile of the distribution compared with the remaining. Results: Among 448 individuals, vascular risk profiles were similar across WMH progression subgroups except age (70.1±7.9 versus 65.7±7.3 years; P <0.001) and systolic blood pressure (128.3±11.0 versus 126.2±9.4 mm Hg; P =0.039). Seventy-two (48.3%) of the top tertile cohort and 177 (59.2%) of the remaining cohort were in the intensive blood pressure arm. Those within the top tertile of progression had a mean WMH progression of 4.7±4.3 mL compared with 0.13±1.0 mL ( P <0.001). Use of angiotensin-converting enzyme inhibitors (odds ratio, 0.36 [95% CI, 0.16–0.79]; P =0.011) and dihydropyridine calcium channel blockers (odds ratio, 0.39 [95% CI, 0.19–0.80]; P =0.011) was associated with less WMH progression, although dihydropyridine calcium channel blockers lost significance when WMH was treated as a continuous variable. Conclusions: Among participants of SPRINT-MIND trial, angiotensin-converting enzyme inhibitor was most consistently associated with less WMH progression independent of blood pressure control and age.
Genetic Regulators of Sputum Mucin Concentration Revealed by GWAS and Their Associations with Chronic Bronchitis and Acute Exacerbations of COPD
Radicioni, Giorgia , Garudadri, S., Curtis, J.L., Krishnan, J.A., Wan, E.S., Silverman, Edwin K. , Hastie, Annette T. , Ortega, Victor E. , Christenson, S., Li, Yingying , Cho, M.H., Kelada, Samir N. P. , Buren, Eric C. Van , O’Neal, Wanda K. , Dang, Hong , Kasela, Silva , Curtis, J.L., Han, MeiLan King , Lappalainen, Tuuli , Li, Y., Cho, M.H. , Kesımer, Mehmet

Mayo Clinic

C66. COPD: GENETICS, GENOMICS, AND EPIGENETICS | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4666-A4666

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4666 Get It

Patient Selection and Outcomes for Bronchoscopic Lung Volume Reduction: A Single Center Experience
Martin, M., Scrodin, M. Dulohery, Edell, E.S., Peikert, T., Edell, Eric S. , Peikert, Tobias

Mayo Clinic

C40. INVESTIGATIONS IN INTERVENTIONAL PULMONOLOGY AND PLEURAL DISEASE | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4096-A4096

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4096 Get It

Implications of a Misdiagnosis
Hu, A.W., Edell, Eric S.

Mayo Clinic

A65. PULMONARY CLINICAL CASES II | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A2057-A2057

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2057 Get It

Analytical Validation of GFRNMR: A Blood-Based Multiple Biomarker Assay for Accurate Estimation of Glomerular Filtration Rate
Fuhrmann, Markus, Santamaría, Amauri Schwäble , Scott, Renee, Meeusen, Jeffrey W. , Fernandes, Marianna, Venz, John, Rothe, Victoria, Stämmler, Frank , Ehrich, J. H. H. , Schiffer, Eric, Schwäble Santamaria, Amauri , Venz, John

Mayo Clinic

Diagnostics | April 30, 2022 | Volume: 12 | Issue: 5 | Pages: 1120

10.3390/diagnostics12051120 | PMID 35626276 Get It

Accurate and precise monitoring of kidney function is critical for a timely and reliable diagnosis of chronic kidney disease (CKD). The determination of kidney function usually involves the estimation of the glomerular filtration rate (eGFR). We recently reported the clinical performance of a new eGFR equation (GFRNMR) based on the nuclear magnetic resonance (NMR) measurement of serum myo-inositol, valine, and creatinine, in addition to the immunoturbidometric quantification of serum cystatin C, age and sex. We now describe the analytical performance evaluation of GFRNMR according to the Clinical and Laboratory Standards Institute guidelines. Within-laboratory coefficients of variation (CV%) of the GFRNMR equation did not exceed 4.3%, with a maximum CV% for repeatability of 3.7%. Between-site reproducibility (three sites) demonstrated a maximum CV% of 5.9%. GFRNMR stability was demonstrated for sera stored for up to 8 days at 2–10°C and for NMR samples stored for up to 10 days in the NMR device at 6 ± 2°C. Substance interference was limited to 4/40 (10.0%) of the investigated substances, resulting in an underestimated GFRNMR (for glucose and metformin) or a loss of results (for naproxen and ribavirin) for concentrations twice as high as usual clinical doses. The analytical performances of GFRNMR, combined with its previously reported clinical performance, support the potential integration of this NMR method into clinical practice.
A Rare Cause of Prevascular (Anterior) Mediastinal Mass
Schmidt, Walker, Hla, Diana, Araoz, Philip, Olson, Eric J., Pennington, Kelly M., Schmidt, Walker M. , Schmidt, Walker, Hla, Diana A. , Araoz, Philip, Olson, Eric J., Pennington, Kelly M.

Mayo Clinic

Annals of the American Thoracic Society | April 29, 2022 | Volume: 19 | Issue: 5 | Pages: 850-853

10.1513/annalsats.202109-1015cc | PMID 35486082 Get It

Selecting venues for AMIA events and conferences: guiding ethical principles
Lehmann, Christoph U. , Hollis, Kate Fultz , Petersen, Carolyn , DeMuro, Paul R. , Subbian, Vignesh , Koppel, Ross , Solomonides, Anthony , Pan, Eric, Fultz Hollis, Kate , Solomonides, Anthony E , Pan, Eric C , Goodman, Kenneth W , Koppel, Ross , Lehmann, Christoph U , Petersen, Carolyn , Subbian, Vignesh , Berner, Eta S. , Adler‐Milstein, Julia , Goodman, Kenneth W.

Mayo Clinic

Journal of the American Medical Informatics Association | April 28, 2022 | Volume: 29 | Issue: 8 | Pages: 1319-1322

10.1093/jamia/ocac073 | PMID 35579334 Get It

Abstract A discussion and debate on the American Medical Informatics Association’s (AMIA) Ethical, Legal, and Social Issues (ELSI) Working Group listserv in 2021 raised important issues related to a forthcoming conference in Texas. Texas had recently enacted a restrictive abortion law and restricted voting rights. Several AMIA members advocated for a boycott of the state and the scheduled conference. The discussion led the AMIA Board of Directors to request that the organization’s Ethics Committee provide general guidance for principle-based venue selection. This document recommends overarching principles for the venue selection for future AMIA events and conferences. Discussions by the AMIA Board, the Ethics Committee, and the ELSI Working Group informed these recommendations, and this document on guiding principles was approved by the AMIA Board of Directors in April 2022.